BusinessShire finalizes megadeal to buy Baxalta with $32b offer By Robert Weisman — Boston GlobeJan. 11, 2016 Reprints Baxalta recently opened offices in Cambridge, Mass. Aram Boghosian for STAT Shire finalizes megadeal to buy Baxalta with $32b offer About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW Tags Baxalta biotech drug makers
Business Bob Herman STAT Plus: Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the stakes
Pharmalot Ed Silverman and Damian Garde STAT Plus: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Special Report Brittany Trang STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
